Home › Blood Disorders › Iowa
Blood Disorders clinical trials in Iowa
3 studies for Blood Disorders are looking for participants at sites in Iowa.
Cities in Iowa
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- The University of Iowa, Iowa City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- The University of Iowa, Iowa City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Iowa Hemophilia and Thrombosis Center, Iowa City
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.